Načítá se...
Long-term effects of recombinant human growth hormone therapy in children with Prader–Willi syndrome
PURPOSE OF REVIEW: Recombinant human growth hormone (hGH) therapy in children with Prader–Willi syndrome (PWS) improves linear growth, body composition, physical strength and agility, and other metabolic parameters. These benefits must be weighed against potential adverse effects, including rare occ...
Uloženo v:
| Vydáno v: | Curr Opin Pediatr |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4396180/ https://ncbi.nlm.nih.gov/pubmed/23782572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOP.0b013e328362c7a2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|